Chu de Nantes
Nantes, 44000, France
NCT Number: NCT03998774
The EquiMolar Oxygen and Nitrous Oxyde mix (EMONO) is listed by the ANSM (National Agency for the Safety of Medicines and Health Products) as drugs with enhanced surveillance. EMONO is a gas composed equally of oxygen and nitrous oxide, presented in bottle. The University Hospital of Nantes is currently conducting a general evaluation of the EMONO use in the hospital context. The department of odontology is part of this movement and wants to study the anxiolytic effect expected during dental care under MEOPA in children in the Dental Care Center. This analysis follows a previous study (MEOPAeDent) that subjectively took into account this anxiolysis.
Looking for future studies?
Notify Me3 year–15 year
All sexes
Observational
Nantes, 44000, France
The EquiMolar Oxygen and Nitrous Oxide Mix (EMONO) is listed by the ANSM (National Agency for the Safety of Medicines and Health Products) as drugs with enhanced surveillance. EMONO is a gas composed equally of oxygen and nitrous oxide, presented in bottle. It has had a marketing authorization in France since 2001. Until 2009, it was reserved for hospital use and emergency vehicles; and indicated in the analgesia of short-term painful acts or during medical assistance. urgency in adults and children, dental sedation in children and frail subjects, and obstetrics. The actual benefit was considered important by the Transparency Committee.
Since 2009, a modification of the MAH for EMONO-based specialties has authorized their release from the hospital reserve, which can now be issued for professional use in city and dental surgery. Given the risks associated with the use of EMONO, in particular its potential for abuse and dependence, the ANSM conditioned its availability outside health facilities to the implementation of a common national RMP. This measure was also accompanied by a national monitoring of pharmacovigilance and addictovigilance. The latter is under the responsibility of CEIP-A of Nantes.
The University Hospital of Nantes is currently conducting a general evaluation of the use of EMONO in the hospital context. The department of odontology is part of this movement and wants to study the anxiolytic effect expected during dental care under EMONO in children in the Dental Care Center. This analysis follows a previous study (MEOPAeDent) that subjectively took into account this anxiolysis.
The analysis of this study will allow us to improve the good use of MEOPA for dental care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Primary Purpose: The main objective of this study is to evaluate the anxiolytic effect of EMONO in children during dental care.
Enrollment: 30
Time frame: 15 minutes
The primary endpoint will be a significant variation of heart rate at 3 key moments of the treatment session:
Time frame: 1 minute
The criterion for assessing the child's stress based on the care taken will be the significant variation in heart rate at another point in the treatment session: at the time of the end of the inhalation and care. Comparison will be made between children having pulptomy or extraction.
Time frame: 1 minute
A Veerkamp Modified VENHAM Anxiety Assessment Scale will also be used before and after dental care ( from 0 to relaxed to 5 for extremely stressed) by the dentist. Comparison will also be made between chidren having pulpotomy or extraction.
Nantes University Hospital
Other
Uncontrolled Prospective Monocentric Study Aiming to Evaluate the Anxiolytic Effect of EMONO in Children During Dental Care
Acronym: MOPEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07076875
Behavior, Dental Care for Children
Cairo, Egypt
View Trial DetailsNCT07478653
Body Weight, Dental Care for Children
Lexington, Kentucky, United States
View Trial DetailsNCT07542639
Abscess, Dental Care for Children
View Trial DetailsNCT06924372
Autoimmune Diseases, Biomarkers
Novi Sad, Serbia
View Trial Details